Johns Hopkins spin-out GreyBug raises $1.5m in series A whilst announcing new CEO.
GreyBug, a life sciences company focused on developing eye disease treatments, announce both $1.5m series A and a new chief executive (CEO).
Michael O’Rourke, an 18-year veteran in ophthalmic leadership and commercialisation and a former member of GreyBug’s scientific advisory board, takes the helm as president and CEO of the Johns Hopkins University spin-out.
He comes in as the firm closed $1.5m in venture backing in a series A round supported by the Maryland Venture Fund, the Abell Foundation, and…
